Effects of an Apple Extract on Glycaemia: The GLU-Pomme Study
GLU-Pomme
Dose-response Effect of an Apple Extract on Postprandial Glycaemia: a Randomised Controlled Trial. The GLU-POMME Study.
1 other identifier
interventional
34
1 country
1
Brief Summary
Postprandial hyperglycaemia can lead to adverse modifications to functional proteins within the body and eventually lead to the development of type 2 diabetes. Previous research by this group has shown that an apple polyphenol extract reduced hyperglycaemia following a high-carbohydrate meal. The aim of this study is to investigate the effects of lower doses of the apple extract on postprandial glycaemia, insulinaemia and plasma gastric inhibitory polypeptide concentrations following a mixed carbohydrate test meal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2016
CompletedFirst Posted
Study publicly available on registry
October 20, 2016
CompletedStudy Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedResults Posted
Study results publicly available
June 17, 2020
CompletedJune 17, 2020
March 1, 2018
10 months
October 19, 2016
January 24, 2020
June 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postprandial Glycaemia
Primary outcome: Area over baseline t+0-30 min for plasma glucose
30 min following the test drink
Secondary Outcomes (13)
Postprandial Insulinaemia
baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink
Postprandial Glucose-dependent Insulinotropic Polypeptide (GIP) Concentrations
baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink
Postprandial Glucagon-like Peptide-1 (GLP-1) Concentrations
baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink
Postprandial C-peptide Concentrations
baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink
Postprandial Non-esterified Fatty Acid (NEFA) Concentrations
baseline and 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240 min following the test drink
- +8 more secondary outcomes
Other Outcomes (2)
7-day Food Diary
Baseline
Women's Health Questionnaire
Baseline
Study Arms (4)
1.2 g apple polyphenols
EXPERIMENTAL1200 mg apple polyphenols delivered in a low sugar drink.
0.9 g apple polyphenols
EXPERIMENTAL900 mg apple polyphenols delivered in a low sugar drink.
0.6 g apple polyphenols
EXPERIMENTAL600 mg apple polyphenols delivered in a low sugar drink.
Placebo
PLACEBO COMPARATORNo polyphenols delivered in a low sugar drink.
Interventions
Drinks will be delivered in random order at 4 separate study visits immediately before a high-carbohydrate meal. Seven days wash-out period will be required between study days.
Eligibility Criteria
You may qualify if:
- Age: 18-70 y
- Male and female
You may not qualify if:
- Body Mass Index 18-35 kg/m2
- Able to understand the information sheet and willing to comply with study protocol
- Able to give informed written consent
- Those diagnosed with Phenylketonuria (PKU)
- Those with known or suspected food and/or paracetamol intolerances, allergies or hypersensitivity
- Women who are known to be pregnant or who are intending to become pregnant over the course of the study
- Women who are breast feeding
- Participation in another clinical trial
- Those who have donated blood within 3 months of the screening visit and participants for whom participation in this study would result in having donated more than 1500 millilitres of blood in the previous 12 months.
- Full Blood Counts and Liver Function test results outside of the normal range.
- Current smokers, or reported giving up smoking within the last 6 months
- History of substance abuse or alcoholism
- Reported history of Cardiovascular disease, diabetes (or fasting glucose ≥ 7.1 mmol/L), cancer, kidney, liver or bowel disease, gastrointestinal disorder or use of drug likely to alter gastrointestinal function
- Unwilling to restrict consumption of specified high polyphenol foods for 48 h before the study
- Weight change \>3kg in preceding 2 months and body mass index \<18 or \>35 kg/m2
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- DIANA Foodcollaborator
Study Sites (1)
Metabolic Research Unit at King's College London
Waterloo Campus, London, SE1 9NH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Wendy Hall
- Organization
- King's College London
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2016
First Posted
October 20, 2016
Study Start
January 1, 2017
Primary Completion
November 1, 2017
Study Completion
February 1, 2018
Last Updated
June 17, 2020
Results First Posted
June 17, 2020
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share